US20010012901A1

US20010012901A1 - Sulphonyl compounds for use as linkers in solid phase and combinatorial synthesis

Info

Publication number: US20010012901A1
Application number: US09/811,950
Authority: US
Inventors: Akito Tanaka; Hideo Tsutsumi
Original assignee: Fujisawa Pharmaceutical Co Ltd
Current assignee: Fujisawa Pharmaceutical Co Ltd
Priority date: 1996-12-30
Filing date: 2001-03-21
Publication date: 2001-08-09
Also published as: WO1998029386A1; EP0948480A1; US6225480B1; JP2001508426A; AUPO440596A0

Abstract

The present invention relates to a linker shown by the following formula (I):

X—S0₂—R¹—(A)_m—R² (I)

wherein R¹is a group of the formula (A):

[wherein

R³, R⁴and R⁵are the same or different hydrogen, etc], etc,

R²is a group which can form a chemical bond to a resin which may be protected by a conventional protective group,

A is lower alkylene, etc,

X is a leaving group, and

m is an integer of 0 or 1,

with proviso that A is (C₂-C₆)alkylene, and m is an integer of 1,

when R¹is a group of the formula (A).

Description

TECHNICAL FIELD

The present invention relates to the field of the solid phase chemistry. More particularly, the present invention provides a linker for solid phase and combinatorial synthesis of an organic compound containing —NH— group in its molecule (e.g. amidino group).

BACKGROUND ART

Chemical methods have been developed recently for the synthesis of combinatorial libraries of various organic compounds such as peptides, benzodiazepines, oligosaccharides, etc. Solid phase methods are often employed to synthesize the combinatorial libraries because it offers advantages over traditional solution-based methods, for examples, a) excess reagents and soluble by-products can be simply removed by resin washing; b) the technique is readily amenable to automation, enabling many compounds to be prepared simultaneously; c) resin bound toxic or hazardous compounds can be handled safely without risk to users or the environment. In combinatorial synthesis using the solid phase synthesis, it is very important to choose a “suitable linker” in accordance with the object compound to be synthesized.

Up to now, however, a linker efficiently available for amidino group in the solid phase synthesis has not been known. Therefore, such linker is desired.

DISCLOSURE OF INVENTION

The linker of the present invention can be shown by the following formula (I):

X—SO₂—R¹—R(A)_m—R² (I)

wherein

R ¹is a group of the formula (A), (B), (C), (D) and (E):

[wherein

R ³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, R¹⁷and R¹⁸are the same or different hydrogen, lower alkyl or lower alkoxy, and

n is an integer of 1 to 3],

R ²is a group which can form a chemical bond to a resin which may be protected by a conventional protective group,

A is lower alkylene or a group of the formula:

—A¹—O—A²—

(wherein A ¹and A²are each lower alkylene),

X is a leaving group, and

m is an integer of 0 or 1,

with proviso that A is (C ₂-C₆)alkylene, and

m is an integer of 1,

when R ¹is a group of the formula (A).

The linker of the present invention can be prepared by the following reaction scheme.

wherein R ¹, R², A, X and m are each as defined above.

The sulfonation reaction can be carried out, for example, in accordance with the methods described in Examples in this specification, but not limited thereto, the reaction can be carried out according to the methods known in this field of the art.

The starting compound (II) or a salt thereof can be prepared according to Preparations in this specification or similar manners thereto, for instance. Further, one can prepare the compound (II) or a salt thereof from a known compound in accordance with the known methods in this field of the art.

In the above and following description of the present specification, suitable examples and illustrations of the various definitions which the present invention includes within the scope thereof are explained in detail as follows.

Suitable “salt” may be the conventional ones and include a metal salt such as an alkali metal salt (e.g. sodium salt, potassium salt, etc) and an alkaline earth metal salt (e.g. calcium salt, magnesium salt, etc), an ammonium salt, an organic base salt (e.g. trimethylamine salt, triethylamine salt, pyridine salt, picoline salt, dicyclohexylamine salt, N,N′-dibenzylethylenediamine salt, etc), an organic acid salt (e.g. acetate, trifluoroacetate, maleate, tartrate, fumarate, methanesulfonate, benzenesulfonate, formate, toluenesulfonate, etc), an inorganic acid salt (e.g. hydrochloride, hydrobromide, hydriodide, sulfate, phosphate, etc), a salt with an amino acid (e.g. arginine, aspartic acid, glutamic acid, etc), and the like.

Suitable “lower alkyl” may include straight or branched ones having 1 to 6 carbon atom(s) such as methyl, ethyl, propyl, isopropyl, butyl, t-butyl, pentyl, hexyl, or the like.

Suitable “lower alkylene” may include straight or branched ones having 1 to 6 carbon atom(s) such as methylene, ethylene, trimethylene, 1-methylethylene, tetramethylene, pentamethylene, hexamethylene, or the like.

Suitable “lower alkoxy” may include straight or branched ones having 1 to 6 carbon atom(s) such as methoxy, ethoxy, prosoxy, isopropoxy, butoxy, t-butoxy, pentyloxy, hexyloxy, or the like.

Suitable “a group which can form a chemical bond to a resin” may be selected in accordance with the kind of resin (e.g. amino-resin, etc) and the concrete examples thereof can be exemplified as follows (the corresponding resin type is also indicated; means “resin”).

1) —COOH (H ₂N—)

2) —NH ₂(HOOC—)(Z—SO₂—; Z means a leaving group)

3) a leaving group (H ₂N—)

4) —C═Pφ ₃; φ means “phenyl” (OHC—)

5) —C═CH ₂(Z—φ—)

6) —C═CH—X ((HO) ₂B-φ—)

7) —CHO (φ ₃P═CH—)(H₂N—) (HO—CH₂CH(OH)CH₂—)

8) —OH (Z—CH ₂—)

9) —SH (Z—CH ₂—)

10) —Si(CH ₃)₂H (H₂C═CH—)

11) —SO ₂Z (H₂N—)

Suitable “protected carboxy” may be the conventionally protected carboxy and may include esterified carboxy such as lower alkoxycarbonyl (e.g. methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, t-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonyl, etc), halo(lower)alkoxycarbonyl (e.g. trichloroethoxycarbonyl, etc) and the like.

Suitable “a leaving group” may include halogen (e.g. fluoro, chloro, bromo, iodo), lower alkoxy as mentioned above, aryloxy (e.g. phenoxy, etc), and the like.

Preferred embodiment of the linker (I) may be as follows.

1. the linker (I) wherein

R ¹is a group of the formula (A) wherein

R ³, R⁴and R⁵are each lower alkyl,

A is (C ₂-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A ¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1,

in which the more preferred one may be the linker (I) wherein

R ¹is a group of the formula:

R ²is carboxy or protected carboxy,

A is trimethylene,

X is chloro, and

m is an integer of 1.

2. the linker (I) wherein

R ¹is a group of the formula (B) wherein

R ⁶, R⁷, R⁸and R⁹are each lower alkyl,

R ¹⁰is hydrogen, and n is an interger of 3,

A is (C ₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A ¹and A²are each (C₁-C₄)alkylene],

X is halogen, and

m is an integer of 0 or 1,

in which the more preferred one may be the linker (I)

wherein

R ¹is a group of the formula:

R ²is carboxy or protected carboxy,

A is methylene or —(CH ₂)₂—O—CH₂—,

X is chloro, and

m is an integer of 1.

3. the linker (I) wherein

R ¹is a group of the formula (B) wherein

R ⁶, R⁷, R⁸, R⁹and R¹⁰are each lower alkyl, and

n is an integer of 3,

A is (C ₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A ¹and A²are each (C₁-C₄)alkylene],

X is halogen, and

m is an integer of 0 or 1,

in which the more preferred one may be the linker (I) wherein

R ¹is a group of the formula:

R ¹is carboxy or protected carboxy,

X is chloro, and

m is an integer of 0, or

R ¹is a group of the formula:

R ²is carboxy or protected carboxy,

A is methylene,

X is chloro, and

m is an integer of 1.

4. the linker (I) wherein

R ¹is a group of the formula (C) wherein

R ¹¹, R¹², R¹³, R¹⁴are each lower alkyl, and

R ¹⁵is hydrogen,

A is (C ₁-C₄)alkylene or a group of the formula:

—A¹—O—A^2—

[wherein A ¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1,

in which the more preferred one may be the linker (I) wherein

R ¹is a group of the formula:

R ²is carboxy or protected carboxy,

A is methylene,

X is chloro, and

m is an integer of 1.

5. the linker (I) wherein

R ¹is a group of the formula (D) wherein

R ¹⁶is lower alkyl,

A is (C ₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A ¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1,

in which the more preferred one may be the linker (I) wherein

R ¹is a group of the formula:

R ²is carboxy or protected carboxy,

A is trimethylene,

X is chloro, and

m is an integer of 1.

6. the linker (I) wherein

R ¹is a group of the formula (E) wherein

R ¹⁷and R¹⁸are each lower alkyl,

A is (C ₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A ¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1,

in which the more preferred one may be the linker (I) wherein

R ¹is a group of the formula:

R ²is carboxy or protected carboxy,

A is methylene,

X is chloro, and

m is an integer of 1.

The linker which the present invention provides is the efficient one for the solid phase synthesis of the compound containing —NH— group such as “amidino” group in its molecule (hereinafter referred to as “amine compound” in this specification). Since there are various therapeutically active “amine compound” and so the present invention is very useful in the solid phase synthesis.

Since the compound (I) of the present invention is “linker”, the “amine compound” to be used is not limited and the present invention can be applied to any “amine compound” which is useful as the key intermediate in the solid phase synthesis and can form a bond to the linker of the present invention during the solid phase reaction, then can be cleaved after the reaction.

As for said “amine compound”, the following compounds can be exemplified, but it is not limited thereto.

1) the compound of the formula:

R^a—NH₂or R^b—NH—R^c

[wherein R ^a, R^band R^care each a residue of an organic group such as lower alkyl, aryl (e.g. phenyl, naphthyl, anthryl, etc)];

2) the compound of the formula:

[wherein R ^dand R^eare each a residue of an organic group such as lower alkyl, aryl (e.g phenyl, naphthyl, anthryl, etc)];

3) heterocyclic compound containing —NH— moiety such as imidazole or its derivative, indole or its derivative, or the like.

Said “amine compound” can be reacted with the linker of the present invention in a conventional manner to form the compound of the formula:

AM—SO₂—R¹—(A)_m—R²

wherein AM is a residue of “amine compound”, and

R ¹, R², A and m are each as defined above.

As for this compound, the preferred “—SO ₂—R¹—(A)_m—R²” moiety can be referred to the ones as exemplified for the linker (I) before.

If “a group which can form a chemical bond to a resin” can also react with said “amine compound”, this group can be protected by a conventional protective group in this field of the art. The protective group can be selected depending on the kind of “a group which can form a chemical bond to a resin”.

During the solid phase synthesis, the linker of the present invention, “amine compound” and “resin” form the following structure.

AM—SO₂—R¹—(A)_m—R² _b—

wherein R ² _bis a chemical bond, is resin, and

AM, R ¹, R², A and m are each as defined above.

In order to show said usefulness, we describe later in this specification the concrete examples (References) which show how the linker of the present invention contributes to the solid phase synthesis of the derivatives of “amine compound” using “benzamidine”, etc as the representative compound.

The following Preparations, Examples and References are given only for the purpose of illustrating the present invention in more detail.

Preparation 1

A mixture of 2,3,5-trimethylphenol (10.0 g), ethyl 4-bromobutyrate (12.6 ml), potassium carbonate (12.2 g), and dimethylformamide (DMF, 100 ml) was stirred at room temperature overnight. The reaction mixture was poured into a mixture of ethyl acetate (AcOEt) and water. The separated organic phase was washed with a saturated aqueous solution of sodium hydrocarbonate (sat. NaHCO ₃aq.), water, and brine, and was dried over magnesium sulfate (MaSO₄). After evaporation, the resulting residue was purified by chromatography over silica gel (CHCl₃as eluent) to give ethyl 4-(2,3,5-trimethylphenoxy)butyrate (16.35 g) as an oil compound.

IR (Neat): 2937, 2870, 1736, 1614, 1583 cm ⁻¹

¹H-NMR (200 MHz, CDCl₃, δ): 1.27 (3H, t, J=7.1 Hz), 2.0-2.4 (2H, m), 2.04 (3H, s), 2.22 (3H, s), 2.27 (3H, s) , 2.50 (2H, t, J=7.4 Hz) , 3.97 (2H, t, J=7.4 Hz), 4.14 (2H, q, J=7.1 Hz), 6.51 (1H, s), 6.60 (1H, s)

MASS spectrum m/e: 251 (M+H ⁺)

EXAMPLE 1

A mixture of chlorosulfonic acid (4.78 ml) and CH[0157] ₂Cl₂(25 ml) was added dropwise into a mixture of ethyl 4-(2,3,5-trimethylphenoxy)butyrate (6.00 g) and dichloromethane (CH₂Cl₂, 500 ml) under ice-water cooling over 10 minutes, and was stirred at room temperature for 2.5 hours. The reaction mixture was poured into a mixture of ice and sat. NaHCO₃ac. The separated organic phase was washed with sat. NaHCO₃aq., water, and brine, and was dried over MgSO₄. After filtration, the filtrate was evaporated to give 4-(3-ethoxycarbonylpropoxy)-2,3,6-trimethylbenzenesulfonyl chloride (16.35 g) as an oil compound.
IR (Neat): 1983, 2940, 1733, 1581, 1558, 1465 cm[0158] ⁻¹
[0159] ¹H-NMR (200 MHz, CDCl₃, δ): 1.27 (3, t, J=7.2 Hz), 2.0-2.4 (2H, m), 2.04 (3H, s), 2.55 (2H, t, J=7.1 Hz), 2.67 (3H, s), 2.71 (3H, s), 4.0-4.2 (4H, m), 6.65 (1H, s)
Reference 1 [0160]
1N NaOH (6.43 ml) was added into a mixture of benzamidine hydrochloride (1.00 g) and acetone (25 ml) under ice-water cooling, and then a mixture of 4-(3-ethoxycarbonylpropoxy)-2,3,6-trimethylbenzenesulfonyl chloride (3.36 g) and acetone (5 ml) was added dropwise thereto over 10 minutes. The reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated by N[0161] ₂flow to remove the excess of solvents, and was poured into a mixture of water and AcOEt. The separated organic phase was washed with sat. NaHCO₃aq., water, and brine, and was dried over MgSO₄. After evaporation, the resulting residue was purified by chromatography over silica gel (CHCl₃-methanol (MeOH) as eluent) to give N-[4-(3-ethoxycarbonylpropoxy)-2,3,6-trimethylbenzenesulfonyl]-benzamidine (1.39 g) as an oil compound.
IR (Neat): 3425, 3328, 1729, 1633, 1585, 1537 cm[0162] ⁻¹
[0163] ¹H-NMR (200 MHz, CDCl₃, δ): 1.29 (3H, t, J=7.1 Hz), 2.0-2.4 (2H, m), 2.10 (3H, s), 2.52 (2H, t, J=7.1 Hz), 2.66 (3H, s), 2.73 (3H, s), 4.03 (2H, t, J=6.0 Hz), 4.14 (2H, q, J=7.1 Hz), 6.55 (1H, s), 7.3-7.6 (3H, m), 7.77 (2H, d, J=6.9 Hz)
MASS spectrum m/e: 433 (M+H[0164] ⁺)
Reference 2 [0165]
A mixture of N-[4-(3-ethoxycarbonylpropoxy)-2,3,6-trimethylbenzenesulfonyl] benzamidine (0.39 g), 1N NaOH (1.80 ml), and ethanol (EtOH, 1 ml) was stirred at room temperature overnight. The reaction mixture was poured into a mixture of ethyl acetate (AcOEt) and dil. HCl. The separated organic phase was washed with water and brine, and was dried over magnesium sulfate (MgSO[0166] ₄). After evaporation, the resulting residue was dissolved with AcOEt. Dicyclohexylamine (0.18 ml) was added thereto, and was evaporated in vacuo. The resulting precipitate was washed with diethyl ether (Et₂O) to give N-[4-(3-carboxypropoxy)-2,3,6-trimethylbenzenesulfonyl]-benzamidine dicyclohexylamine salt (16.35 g).
mp: 157-160° C. [0167]
IR (KBr): 3371, 2939, 2859, 1618, 1552, 1446 cm[0168] ⁻¹
[0169] ¹H-NMR (200 MHz, CDCl₃, δ): 1.0-3.0 (26H, m), 2.14 (3H, s), 2.38 (2H, t, J=7.1 Hz), 2.65 (3H, s), 2.71 (3H, s), 4.03 (2H, t, J=6.3 Hz), 6.55 (1H, s), 6.59 (1H, brs), 7.2-7.6 (6H, m), 7.78 (2H, d, J=7.1 Hz)
MASS spectrum m/e: 405 (M+H[0170] ⁺ of free)
Anal. Calcd. for C[0171] ₃₂H₄₇N₃O₅S: C, 65.61; H, 8.09; N, 7.17 Found: C, 65.65; H, 8.44; N, 6.71
Reference 3 [0172]
N-[4-(3-Carboxypropoxy)-2,3,6-trimethylbenzenesulfonyl]-benzamidine dicyclohexylamine salt (586 mg) was dissolved with a mixture of dil. HCl and CH[0173] ₂Cl₂. The separated organic layer was washed with water and brine, and dried over MgSO₄. After filtration, 1-(3-dimethylamino-propyl)ethylcarbodiimide hydrochloride (211 mg) and 1-hydroxybenzotriazole (149 mg) were added to the filtrate. The reaction mixture was mixed with aminomethylated polystyrene resin (0.78 mmol/g, 586 mg), was shook by N₂bubbling at room temperature for 2.5 hours. The Ninhydrin test on the reaction resin was negative at the end of the reaction. The resin was washed 5 times with CH₂Cl₂. After dried by N₂flow, 20% acetic anhydride in CH₂Cl₂(50 ml) was added thereto to complete capping of the resin. The resin was washed with CH₂Cl₂5 times, and dried by N₂flow and in vacuo to give “compound 1” (771 mg).
Reference 4 [0174]
The “resin 1” (187 mg) was mixed with a mixture of m-cresol (0.04 ml), thioanisole (0.24 ml), 1,2-ethanedithiol (0.12 ml), trimethylsilylbromide ( 0.27 ml), and trifluoroacetic acid (TFA, 1.3 ml). The reaction mixture was heated at 80° C. for 13 hours. After filtration, the resin was washed with TFA 3 times. The combined filtrate was concentrated by N[0175] ₂flow, and was poured into Et₂O (6 ml), which resulted in white precipitation. The mixture was cooled by dry-ice for 1 hour, and was centrifuged at 3000 rpm for 3 minutes. This washing operation was repeated twice. The resulting precipitate was dried to give benzamidine trifluoroacetate (13.2 mg).
mp: 214° C. (decomp.) [0176]
Anal. Calcd. for C[0177] ₇H₈N₂.CF₃COOH.0.6H₂O: C, 44.13; H, 4.20; N, 11.43 Found: C, 44.30; H, 3.99; N, 11.05
The retention time of HPLC under the following conditions of the product was consistent with an authentic sample. [0178]
HPLC conditions: [0179]
Column; YMC-PACK R-ODS-15 S-15 120A ODS (YMC Co., Ltd.), [0180]
4.6φ×250 mm; [0181]
Flow, 1 ml/min; [0182]
Detection, 254 nm; [0183]
Retention time, 6.74 min; [0184]
Elution program was shown in Table 1. [0185]

TABLE 1

Time program for the HPLC study

0 6.00 6.01 8.00 8.01 minute

5 5 80 80 5 % CH₃CN in 0.1% TEA aq.
Preparation 2 [0186]
A mixture of 4-(2,3,5-trimethylphenoxy)butyrate (9.09 g), 1N NaOH (58 ml), and EtOH (80 ml) was stirred at room temperature overnight. The reaction mixture was poured into mixture of Et[0187] ₂O and water. The separated water phase was washed with Et₂O, and was acidified by 6N HCl. After extraction by AcOEt, the AcOEt was washed with water and brine, and dried over MgSO₄, and then evaporated. The resulting precipitate was collected by filtration, and dried to give 4-(2,3,5-trimethylphenoxy)butyric acid (4.91 g).
mp: 90-93° C. [0188]
IR (KBr): 2913, 1712, 1581 cm[0189] ⁻¹
[0190] ¹H-NMR (200 MHz, CDCl₃, δ): 1.94 (2H, tt, J=7.1 and 6.3 Hz), 2.01 (3H, s), 2.15 (3H, s), 2.01 (3H, s), 3.40 (2H, t, J=7.1 Hz;, 3.91 (2H, t, J=6.3 Hz), 6.56 (1H, s), 6.57 (1H, s), 12.12 (1H, br s)
MASS spectrum m/e: 223 (M+H[0191] ⁺)
Preparation 3 [0192]
A mixture of 4-(2,3,5-trimethylphenoxy)butyric acid (4.82 mg) dimethylaminopyridine (DMAP, 0.26 g), 2,2,2-trichloroethanol (2.50 ml), 1-(3-dimethylaminopropyl)-ethylcarbodiimide hydrochloride (4.57 g) and CH[0193] ₂Cl₂was stirred at room temperature overnight. The reaction mixture was poured into a mixture of AcOEt and water. The separated AcOEt was washed with dil. HCl, sat. NaHCO₃, water, and brine, and dried over MgSO₄, and then evaporated to give 2,2,2-trichloroethyl 4-(2,3,5-trimethylphenoxy)butyrate (8.11 g) as an oil compound.
IR (KBr): 2925, 1754, 1612, 1581 cm[0194] ⁻¹
[0195] ¹H-NMR (200 MHz, CDCl₃, δ): 2.01 (3H, s), 2.04 (2H, m), 2.15 (3H, s) , 2.04 (3H, s), 2.67 (2H, t, J=7.1 Hz), 3.97 (2H, t, J=6.3 Hz), 6.81 (2H, br s)
MASS spectrum m/e: 353 (M[0196] ⁺)

EXAMPLE 2

The following compound was obtained according to a similar manner to that of Example 1. [0197]
4-[3-(2,2,2-Trichloroethoxy)carbonylpropoxy]-2,3,6-trimethylbenzenesulfonyl chloride (6.40 g) as an oil compound. [0198]
IR (Neat): 2939, 1756, 1681, 1606, 1583, 1556 cm[0199] ⁻¹
[0200] ¹H-NMR (200 MHz, CDCl₃, δ): 2.01 (3H, s), 2.04 (2H, m), 2.15 (3H, s), 2.04 (3H, s), 2.67 (2H, t, J=7.1 Hz), 3.97 (2H, t, J=6.3 Hz), 6.84 (1H, s)
MASS spectrum m/e: 451 (M−H[0201] ⁺)
Reference 5 [0202]
The following compound was obtained according to a similar manner to that of Reference 1. [0203]
4-Ethoxycarbonylpropoxy-N-{4-[3-(2,2,2-trichloroethoxy-carbonyl(propoxy]-2,3,6-trimethylbenzenesulfonyl}benzamidine (3.28 g) as an oil compound. [0204]
[0205] ¹H-NMR (200 MHz, CDCl₃, δ): 1.17 (3H, t, J=7.1 Hz), 1.8-2.1 (4H, m), 2.22 (3H, s), 2.4-2.8 (10H, m), 4.0-4.2 (6H, m), 4.90 (2H, s), 6.75 (1H, s), 6.99 (2H, d, J=8.9 Hz), 7.82 (2H, d, J=8.9 Hz), 7.83 (1H, br s), 8.76 (1H, s)
MASS spectrum m/e: 667 (M+H[0206] ⁺)
Reference 6 [0207]
Zn powder (0.32 g) was added to a mixture of 4-ethoxycarbonylpropoxy-N-{4-[3-(2,2,2-trichloroethoxy-carbonyl)propoxy]-2,3,6-trimethylbenzenesulfonyl}benzamidine (0.65 g), water (2 ml), and AcOH (18 ml) under ice-water cooling. The reaction mixture was stirred at room temperature for 3.25 hours, and then evaporated. The resulting precipitate was removed by filtration, and was washed with AcOEt and isopropyl ether (IPE). The filtrate, AcOEt, and IPE were combined, and then washed with water. The organic phase was dried over MgSO[0208] ₄, and evaporated. The resulting residue was purified by chromatography over silica gel (CHCl₃—MeOH as eluent) to give 4-ethoxycarbonylpropoxy-N-[ 4-(3-carboxypropoxy)-2,3,6-trimethylbenzenesulfonyl]-benzamidine (0.17 g) as an oil compound.
IR (Neat): 3424, 3330, 3243, 2973, 1725, 1720, 1635 cm[0209] ⁻¹
[0210] ¹H-NMR (200 MHz, CDCl₃, δ): 1.17 (3H, t, J=7.1 Hz), 1.8-2.1 (4H, m), 2.22 (3H, s), 2.4-2.8 (10H, m), 4.0-4.2 (6H, m) , 4.90 (2H, s), 6.75 (1H, s), 6.99 (2H, d, J=8.9 Hz), 7.82 (2H, d, J=8.9 Hz), 7.83 (1H, br s), 8.76 (1H, s)
MASS spectrum m/e: 535 (M+H[0211] ⁺)
Anal. Calcd. for C[0212] ₂₆H₃₄N₂O₈S.1/4H₂O: C, 57.92, H; 6.45; N; 5.20 Found: C, 57.93; H, 6.45; N; 5.06
Reference 7 [0213]
A mixture of 4-ethoxycarbonylpropoxy-N-[4-(3-carboxypropoxy)-2,3,6-trimethylbenzenesulfonyl]benzamidine (1.00 g), 1-(3-dimethylaminopropyl)ethylcarbodiimide hydrochloride (0.39 g), aminomethylated polystyrene resin (ArgoGel[0214] ^R0.41 mmol/g, 1.14 g), 1-hydroxybenzotriazole (149 mg), CH₂Cl₂(5 ml), and DMF (5 ml) was shocked by N₂bubbling at room temperature for 2 hours. The Keiser test on the reaction resin was negative at the end of the reaction. The resin was washed 5 times with CH₂C₂and DMF, and dried by N₂flow to give the following “compound 2”, which was used in the next reaction without further treatment.
Reference 8 [0215]
A mixture of the above resin (2, assumed 0.47 mmol according to Reference 7), 1N NaOH (1.56 ml), and EtOH (10 ml) was shook by N[0216] ₂bubbling room temperature overnight. The end of the reaction was determined by solid phase ¹H-NMR on the resin using nanoprobe (Varian Unity plus 300). The resin was washed with EtOH, water, 0.5N HCl, CH₂Cl₂, and DMF, and dried by N₂flow to give the following “compound 3”, which was used in the next reaction without further treatment.
Reference 9 [0217]
A mixture of the above resin (3, assumed 0.47 mmol according to Reference 7), H-Asp(OtBu)ValOtBu (0.53 g), 1-(3-dimethylaminopropyl)ethylcarbodiimide hydrochloride (0.30 g), 1-hydroxybenzotriazole (0.21 g), and CH[0218] ₂Cl₂(15 ml) was shocked by N₂bubbling at room temperature for 9 hours. The end of the reaction was determined by solid phase ¹H-NMR on the resin using nanoprobe (Varian Unity plus 300). The resin was washed with CH₂Cl₂, and DMF, and dried by N₂flow to give the following “compound 4”, which was used in the next reaction without further treatment.
Reference 10 [0219]
The resin 4 (assumed 0.47 mmol according to Reference 7), was mixed with a mixture of trifluoromethanesulfonic acid (TfOH, 0.8 ml), thioanisole (TA, 0.8 ml), and TFA (7.2 ml). The reaction mixture was stirred under water cooling for 2.5 hours. After filtration, the resin was washed with TFA 3 times. The combined filtrate was concentrated by N[0220] ₂flow, and was poured into a mixture of water (40 ml) and Et₂O (40 ml). The mixture was adjusted to pH 2.08 by addition of 1N NaOH. The separated water phase was subjected to preparative HPLC under the below conditions to give the following compound 5 (57.0 mg, 56.3% from Reference 7).
mp: 155-158° C. [0221]
IR (KBr): 3332, 3118, 1718, 1668, 1614 cm[0222] ⁻¹
[0223] ¹H-NMR (DMSO-d₆, δ): 0.84 (6H, d, J=6.7 Hz), 1.8-2.2 (3H, m), 2.30 (2H, t, J=7.3 Hz), 2.3-2.8 (2H, m), 4.0-4.2 (3H, m), 4.65 (1H, m), 7.14 (2H, d, J=8.9 Hz) , 7.79 (1H, d, J=8.5 Hz) , 7.82 (2H, d, J=8.9 Hz), 8.30 (1H, d, J=7.7 Hz), 9.03 and 9.14 (4H, each s)
MASS spectrum m/e: 437 (M+H[0224] ⁺)
Preparative HPLC conditions: Column, YMC-PACK R-ODS-15 S-15 120A ODS (YMC Co., Ltd.), 50 φ×250 mm; Elution, 16% CH[0225] ₃CN in 0.1% TFAaq., Flow, 118 ml/min; Detection, 254 nm; Retention time, 6.5 min.
The purity of the product was confirmed by RP-HPLC under the following conditions, and the retention time was consistent with an authentic sample. [0226]
Analytical HPLC conditions: Column, YMC-PACK R-ODS-15 S-15 120A ODS (YMC Co., Ltd), 4.6φ×250 mm; Flow, 1 ml/min; Detection, 254 nm; Retention time, 6.7 min; Elution 18% CH[0227] ₃CN in 0.1% TFA ac.
Preparation 4 [0228]
According to the method of G. Manecke and G. Bourweig (Chem. Ber., 1959, 92, 2958-61), 2-hydroxy-3,4,6-trimethyl-benzaldehyde was synthesized from 2,3,5-trimethylphenol. [0229]
Preparation 5 [0230]
A suspension of 2-hydroxy-3,4,6-trimethylbenzaldehyde (16.45 g), diethyl isopropylidenemalonate (20.05 g), and anhydrous potassium carbonate (40.10 g) in dimethylformamide (DMF) (11) was heated at 130-135° C. for 8 hours. After removing the solvent under reduced pressure, the mixture was diluted with water, and extracted with ethyl acetate (AcOEt). The organic phase was washed with water and brine, dried over magnesium sulfate (MgSO[0231] ₄), and evaporated to give a residue. The residue was purified by chromatography over silica gel (AcOEt-hexane 3:97 as eluent) to give ethyl (2,5,7,8-tetramethyl-2H-chromen-2-yl)acetate as an oil (22.45 g).
bp: 152-153° C. (2 mm) [0232]
IR (Neat): 1735, 1608 cm[0233] ⁻¹
[0234] ¹H-NMR (200 MHz, CDCl₃, δ): 1.23 (3H, t, J=7.1 Hz), 1.57 (3H, s), 2.07 (3H, s), 2.19 (3H, s), 2.23 (3H, s), 2.67 and 2.71 (2H, ABq, J=14.0 Hz), 4.11 (2H, q, J=7.1 Hz), 5.72 (1H, d, J=9.9 Hz), 6.54 (1H, s), 6.55 (1H, d, J=9.9 Hz)
MASS spectrum m/e: 275 (M+H[0235] ⁺), 187 (M⁺—CH₂CO₂Et)
Preparation 6 [0236]
A solution of ethyl (2,5,7,8-tetramethyl-2H-chromen-2-yl)acetate (20.00 g) in methanol (MeOH) (300 ml) was hydrogenated in the presence of 10% palladium on carbon (50% wet, 4.0 g) in one atmosphere of hydrogen at room temperature for 16 hours. The catalyst was filtered off and MeOH was removed under reduced pressure to give a residue. The residue was purified by chromatography over silica gel (AcOEt-hexane 3:97 as eluent) to give ethyl (2,5,7,8-tetramethylchroman-2-yl)acetaze as an oil (18.72 g). [0237]
bp: 157-159° C. (2 mm) [0238]
IR (Neat): 1732, 1575 cm[0239] ⁻¹
[0240] ¹H-NMR (200 MHz, CDCl₃, δ): 1.26 (3H, t, J=7.1 Hz), 1.43 (3H, s), 1.8-2.1 (2H, m), 2.05 (3H, s), 2.16 (3H, s), 2.19 (3H, s), 2.55-2.75 (4H, m), 4.15 (2H, q, J=7.1 Hz), 6.57 (1H, s)
MASS spectrum m/e: 277 (M+H[0241] ⁺), 189 (M⁻—CH₂CO₂Et)
Anal. Calcd. for C[0242] ₁₇H₂₄O₃: C, 73.88; H, 8.75 Found: C, 73.99; H, 8.95

EXAMPLE 3

A solution of chlorosulfonic acid (2.79 ml) in dichloromethane (CH[0243] ₂Cl₂) (15 ml) was added dropwise to a solution of ethyl (2,5,7,8-tetramethylchroman-2-yl)acetate (2.90 g) in CH₂Cl₂(100 ml) at 0-10° C. over an hour. After stirring at room temperature for 5 hours, the reaction mixture was poured into chilled saturated aqueous sodium hydrogen carbonate (sat. as. NaHCO₃). The separated organic phase was washed with sat. aq. NaHCO₃, water, and brine, and dried over MgSO₄. After filtration, the filtrate was concentrated under reduced pressure to give 2-ethoxycarbonylmethyl-2,5,7,8-tetramethylchroman-6-sulfonyl chloride as a syrup (3.29 g).
IR (Neat): 1720, 1550 cm[0244] ⁻¹
Reference 11 [0245]
To a suspension of benzamidine hydrochloride (2.72 g) in acetone (70 ml) was added EN aqueous sodium hydroxide (1N N[0246] _aOH) (17.3 ml) under ice-cooling. To the mixture of a solution of 2-ethoxycarbonylmethyl-2,5,7,8-tetramethyl-chroman-6-sulfonyl chloride (3.25 g) in acetone (15 ml) was added dropwise over 15 minutes under ice-cooling, and stirred at room temperature for 20 hours. Acetone was removed under reduced pressure to give a residue. To the residue was added a mixture of water and AcOEt and the mixture was acidified with 1N HCl. The separated organic phase was washed with water and brine, and dried over MgSO₄. After filtration, the filtrate was evaporated and purified by chromatography over silica gel (AcOEt-hexane 50:50 as eluent) to give N-(2-ethoxycarbonylmethyl-2,5,7,8-tetramethylchroman-6-sulfonyl)benzamidine as a glass (1.60 g).
IR (CHCl[0247] ₃): 3450, 3350, 1730, 1630, 1532 cm⁻¹
[0248] ¹H-NMR (200 MHz, CDCl₃, δ): 1.26 (3H, t, J=7.1 Hz,, 1.43 (3H, s), 1.8-2.15 (2H, m), 2.11 (3H, s), 2.6-2.75 (10H, m), 4.15 (2H, q, J=7.1 Hz), 6.23 (1H, br s), 7.35-7.6 (3H, m), 7.75-7.85 (2H, m), 8.14 (1H, br s)
MASS spectrum m/e: 459 (M+H[0249] ⁺)
Anal. Calcd. for C[0250] ₂₄H₃₀N₂O₅S: C, 62.86; H, 6.59; N, 6.11 Found C, 62.78; H, 6.60; N, 6.00
Reference 12 [0251]
A solution of N-(2-ethoxycarbonylmethyl-2,5,7,8-tetramethylchroman-6-sulfonyl)benzamidine (1.54 g) in a mixture of ethanol (EtOH) (30 ml) and 1N NaOH (7.05 ml) was stirred at room temperature for 30 hours. EtOH was evaporated under reduced pressure to give a residue. A mixture of AcOEt and 1N HCl was added to the residue. The organic phase was washed with water and brine, and dried over MgSO[0252] ₄. After filtration, the filtrate was concentrated under reduced pressure to give N-(2-carboxymethyl-2,5,7,8-tetramethylchroman-6-sulfonyl)benzamidine as a glass (1.49 g).
IR (CHCl[0253] ₃): 3450, 3350, 1710, 1630, 1535 cm⁻¹
[0254] ¹H-NMR (200 MHz, CDCl₃, δ): 1.45 (3H, s), 1.75-2.1 (5H, m), 2.5-2.7 (10H, m), 6.40 (1H, br s), 7.3-7.55 (3H, m), 7.75-7.8 (2H, m), 8.12 (1H, br s)
MASS spectrum m/e: 431 (M+H[0255] ⁺), 373
Reference 13 [0256]
A solution of dicyclohexylamine (0.54 g) in AcOEt (1 ml) was added to a solution of N-(2-carboxymethyl-2,5,7,8-tetramethylchroman-6-sulfonyl)benzamidine (1.27 g) in AcOEt (11 ml) at room temperature. Diisopropyl ether (10 ml) was added and the mixture was stirred at room temperature to give N-(2-carboxymethyl-2,5,7,8-tetramethylchroman-6-sulfonyl)-benzamidine dicyclohexylamine salt as a solid (1.59 g). [0257]
mp: 201-204° C. [0258]
IR (Nujol): 3350, 1620, 1550, 1530 cm[0259] ⁻¹
[0260] ¹H-NMR (200 MHz, CDCl₃, δ): 1.1-2.9 (28H, m), 1.45 (3H, s), 2.11 (3H, s), 2.60 (3H, s), 2.62 (3H, s), 5.40 (2H, br s), 6.36 (1H, br s), 7.35-7.55 (3H, m), 7.75-7.85 (2H, m), 8.10 (1H, br s)
MASS spectrum m/e: 431 (M+H[0261] ⁺ of free)
Anal. Calcd. for C[0262] ₃₄H₄₉N₃O₅S: C, 66.74; H, 8.07; N, 6.87 Found: C, 66.36; H, 8.29; N, 6.70
Preparation 7 [0263]
A solution of ethyl (2,5,7,8-tetramethylchroman-2-yl)-acetate (8.00 g) in tetrahydrofuran (THF) (16 ml) was added dropwise to the suspension of lithium aluminum hydride (1.10 g) in THF (40 ml) under reflux. After refluxing for 2 hours, a solution of water (1 ml) in THF (5 ml) was added to the reaction mixture. The insoluble material was filtered off and the filtrate was concentrated under reduced pressure to give a residue. The residue was purified by chromatography over silica gel (AcOEt-hexane 10:90) to give 2-(2,5,7,8-tetramethylchroman-2-yl)ethanol as a solid (5.00 g). [0264]
mp: 67-69° C. [0265]
IR (Nujol): 3400, 1460 cm[0266] ⁻¹
[0267] ¹H-NMR (200 MHz, CDCl₃, δ): 1.30 (3H, s), 1.7-2.0 (4H, m), 2.05 (3H, s), 2.16 (3H, s), 2.20 (3H, s), 2.26 (1H, s), 2.63 (2H, t, J=6.8 Hz), 3.8-4.0 (2H, m), 6.58 (1H, s)
MASS spectrum m/e: 235 (M+H[0268] ⁺), 189, 149
Anal. Calcd. for C[0269] ₁₅H₂₂O₂: C, 76.88; H, 9.46 Found: C, 76.92; H, 9.61
Preparation 8 [0270]
A solution of potassium tert-butoxide (1.92 g) in THF (10 ml) was added dropwise to a solution of 2-(2,5,7,8-tetramethylchroman-2-yl)ethanol (4.00 g) and ethyl bromoacetate (2.00 ml) in THF (20 ml) at 0-10° C. and the mixture was stirred for 30 minutes under same condition. After addition of ethyl bromoacetate (1.90 ml), a solution of potassium tert-butoxide (1.92 g) in THF (10 ml) was added dropwise and the mixture was stirred at 0-10° C. for 30 minutes. This procedure was repeated 3 times. A solution of NaOH (5.0 g) in water (10 ml) was added and heated at 50-55° C. for 5 hours. The mixture was adjusted to pH 3 with 6N hydrochloric acid (6N HCl) and extracted with AcOEt. The organic phase was dried over MgSO[0271] ₄and concentrated under reduced pressure to give a syrup. A mixture of the syrup and a cation-exchange resin, Amberlyst® 15 (1 g) in MeOH (100 ml) was heated under reflux for 30 hours. After removal of catalyst, the solution was concentrated under reduced pressure to give a syrup. The syrup was purified by chromatography over silica gel (AcOEt-hexane 5:95) to give methyl [2-(2,5,7,8-tetramethylchroman-2-yl)ethoxy]acetate as an oil (3.37 g).
IR (Neat): 1755, 1575 cm[0272] ⁻¹
[0273] ¹H-NMR (200 MHz, CDCl₃, δ): 1.30 (3H, s), 1.75-2.1 (4H, m), 2.10 (3H, s), 2.15 (3H, s), 2.19 (3H, s), 2.60 (2H, t, J=6.5 Hz), 3.6-3.85 (2H, m), 3.74 (3H, s), 4.08 (2H, s), 6.55 (1H, s)
MASS spectrum m/e: 307 (M+H[0274] ⁺), 279, 217, 149
Anal. Calcd. for C[0275] ₁₈H₂₆O₄: C, 70.56; H, 8.55 Found: C, 70.60; H, 8.70

EXAMPLE 4

2-[2-(Methoxycarbonylmethoxy)ethyl]-2,5,7,8-tetramethylchroman-6-sulfonyl chloride was obtained according to a similar manner to that of Example 3. [0276]
IR (Neat): 1752, 1549 cm[0277] ⁻¹
[0278] ¹H-NMR (200 MHz, CDCl₃, δ): 1.35 (3H, s), 1.8-2.05 (4H, m), 2.14 (3H, s), 2.60 (3H, s), 2.63 (3H, s), 2.65-2.75 (2H, m), 3.55-3.85 (2H, m), 3.76 (3H, s), 4.09 (2H, s)
Reference 14 [0279]
N-{2-[2-(Methoxycarbonylmethoxy)ethyl]-2,5,7,8-tetramethylchroman-6-sulfonyl}benzamidine was obtained according to a similar manner to that of Reference 11. [0280]
IR (CHCl[0281] ₃): 3420, 3320, 1740, 1625, 1530 cm⁻¹
[0282] ¹H-NMR (200 MHz, CDCl₃, δ): 1.30 (3H, s), 1.8-2.05 (4H, m), 2.11 (3H, s), 2.61 (3H, s), 2.63 (3H, s, 2.6-2.7 (2H, m), 3.55-3.85 (2H, m), 3.75 (3H, s), 4.08 (2H, s), 6.18 (1H, br s), 7.35-7.6 (3H, m), 7.75-7.85 (2H, m), 8.13 (1H, br s)
MASS spectrum m/e: 489 (M+H[0283] ⁺)
Anal. Calcd. for C[0284] ₂₅H₃₂N₂O₆S: C, 61.46; H, 6.60; N, 5.73 Found: C, 61.15; H, 6.72; N, 5.61
Reference 15 [0285]
N-{2-[2-(Carboxymethoxy)ethyl]-2,5,7,8-tetramethyl-chroman-6-sulfonyl}benzamidine was obtained according to a similar manner to that of Reference 12. [0286]
IR (CHCl[0287] ₃): 3420, 3330, 3230, 1720, 1623, 1528 cm⁻¹
[0288] ¹H-NMR (200 MHz, CDCl₃, δ) : 1.30 (3H, s), 1.8-2.05 (4H, m), 2.10 (3H, s), 2.5-2.7 (2H, m), 2.60 (3H, s), 2.61 (3H, s), 3.6-3.85 (2H, m), 4.10 (2H, m), 6.32 (1H, br s), 7.35-7.55 (3H, m), 7.75-7.8 (2H, m), 8.12 (1H, br s)
Reference 16 [0289]
N-{2-[2-(Carboxymethoxy)ethyl]-2,5,7,8-tetramethyl-chroman-6-sulfonyl}benzamidine dicvclohexylamine salt was obtained according to a similar manner to that of Reference 13. [0290]
mp: 184-186° C. [0291]
IR (Nujol): 3380, 1622 cm[0292] ⁻¹
[0293] ¹H-NMR (200 MHz, CDCl₃, δ): 1.28 (3H, s), 2.09 (3H, s), 2.59 (3H, s), 2.61 (3K, s), 3.84 (2H, s), 7.11 (1H, br s), 7.25-7.55 (3H, m) , 7.75-7.85 (2H, m) 8.01 (1H, br s)
MASS spectrum m/e: 475 (M+H[0294] ⁺ of free)
Anal. Calcd. for C[0295] ₃₆H₅₃N₃O₆S: C, 65.92; H, 8.14; N, 6.41 Found: C, 65.65; H, 8.39; N, 6.29
Preparation 9 [0296]
According to the method of D. Murali and G. S. Krishna Rao (Synthesis, 1987, 254-56), 5,6,7,8-tetrahydro-3-methyl-1-naphthyl acetate was synthesized from cyclohexanone and triethyl 3-methyl-4-phosphonocrotonate. [0297]
Preparation 10 [0298]
A solution of 5,6,7,8-tetranydro-3-methyl-1-naphthyl acetate (11.00 g) and NaOH (6.50 g) in a mixture of water (50 ml) and MeOH (150 ml) was refluxed for 5 hours. MeOH was removed under reduced pressure to give a residue. AcOEt was added to the residue and c-HCl was added dropwise under ice-cooling. The organic phase was washed with brine and dried over MgSO[0299] ₄. After filtration, the filtrate was concentrated under reduced pressure to give 5,6,7,8-tetrahydro-3-methyl-1-naphthol as a solid (8.19 g).
mp: 94-95° C. (hexane) [0300]
IR (Nujol): 3450-3350, 1623, 1582 cm[0301] ⁻¹
[0302] ¹H-NMR (200 MHz, CDCl₃, δ): 1.65-1.9 (4H, m), 2.23 (3h, s), 2.58 (2H, t, J=6.0 Hz), 2.70 (2H, t, J=5.8 Hz), 4.61 (1H, s), 6.44 (1H, s), 6.51 (1H, s)
MASS spectrum m/e: 163 (M+H[0303] ⁺)
Preparation 11 [0304]
A suspension of boric acid (5.88 g) in glycerol (20 ml) was heated at 170° C. for 30 minutes. Temperature of the reaction mixture was lowered at 155° C. and 5,6,7,8-tetrahydro-3-methyl-1-naphthol (5.00 g) was added dropwise over 10 minutes. After 15 minutes, hexamethylenetetramine (4.35 g) was added dropwise below 180° C. and stirred at 170° C. for 30 minutes. The mixture was cooled to 110° C. and 24% aqueous sulfuric acid (20 ml) was added. The mixture was steam distilled and AcOEt was added to the distillate. The organic phase was washed with brine and dried over MgSO[0305] ₄. After filtration, the filtrate was concentrated under reduced pressure to give 5,6,7,8-tetrahydro-1-hydroxy-3-methylnaphthalene-2-carbaldehyde as a solid (2.15 g). A pure sample was obtained by recrystallization from EtOH—H₂O.
mp: 74-75° C. (EtOH—H[0306] ₂O)
IR (Nujol): 1625 cm[0307] ⁻¹
[0308] ¹H-NMR (200 MHz, CDCl₃, δ) 1.7-1.85 (4H, m), 2.52 (3H, s), 2.6-2.75 (4H, m), 6.44 (1H, s), 10.20 (1H, s), 12.35 (1H, s)
MASS spectrum m/e: 191 (M+H[0309] ⁺), 175
Anal. Calcd. for C[0310] ₁₂H₁₄O₂: C, 75.76; H 7.42 Found: C, 75.96; H 7.55
Preparation 12 [0311]
Ethyl (7,8,9,10-tetrahydro-2,5-dimethyl-2H-naphtho-[ 2,1-e]pyran-2-yl)acetate was obtained according to a similar manner to that of Preparation 5. [0312]
IR (Neat): 1735, 1605 cm[0313] ⁻¹
[0314] ¹H-NMR (200 MHz, CDCl₃, δ) 1.23 (3H, t, J=7.1 Hz), 1.56 (3H, s), 1.65-1.8 (4H, m,, 2.23 (3H, s), 2.55-2.8 (6H, m), 4.11 (2H, q, J=7.1 Hz), 5.69 (1H, d, J=10.0 Hz), 6.46 (1H, s), 6.53 (1H, d, J=10.0 Hz)
MASS spectrum m/e: 301 (M+H[0315] ⁺), 213 (M⁺—CH₂CO₂Et)
Anal. Calcd. for C[0316] ₁₉H₂₄O₃: C, 75.97; H, 8.05 Found: C, 75.54; H, 8.13
Preparation 13 [0317]
Ethyl (3,4,7,8,9,10-hexahydro-2,5-dimethyl-2H-naphtho-[ 2,1-e]pyran-2-yl)acetate was obtained according to a similar manner to that of Preparation 6. [0318]
IR (Neat): 1730, 1578 cm[0319] ⁻¹
[0320] ¹H-NMR (200 MHz, CDCl₃, δ) 1.26 (3H, t, J=7.1 Hz), 1.42 (3H, s), 1.7-1.75 (4H, m), 1.8-2.15 (2H, m), 2.16 (3H, s), 2.5-2.65 (8H, m), 4.14 (2H, q, J=7.1 Hz), 6.50 (1H, s)
MASS spectrum m/e: 303 (M+H[0321] ⁺), 215 (M⁺—CH₂CO₂Et)
Anal. Calcd. for C[0322] ₁₉H₂₆O₃: C, 75.46; H, 8.67 Found: C, 75.32; H, 8.82

EXAMPLE 5

2-Ethoxycarbonylmethyl-3,4,7,8,9,10-hexahydro-2,5-dimethyl-2H-naphtho[2,1-e]pyran-6-sulfonyl chloride was obtained according to a similar manner to that of Example 3. [0323]
IR (Neat): 1730, 1705 cm[0324] ⁻¹
Reference 17 [0325]
N-(2-Ethoxycarbonylmethyl-3,4,7,8,9,10-hexahydro-2,5-dimethyl-2H-naphtho[2,1-e]pyran-6-sulfonyl)benzamidine was obtained according to a similar manner to that of Reference 11. [0326]
IR (CHCl[0327] ₃): 3450, 3350, 1725, 1630, 1533 cm⁻¹
[0328] ¹H-NMR (200 MHz, CDCl₃, δ): 1.26 (3H, t, J=7.1 Hz), 1.43 (3H, s), 1.6-1.75 (4H, m), 1.8-2.3 (2H, m), 2.6-2.7 (9H, m), 3.27 (2H, br s), 4.14 (2H, q, J=7.1 Hz), 6.22 (1H, br s), 7.35-7.6 (3H, m), 7.75-7.8 (2H, m) , 8.16 (1H, br s)
MASS spectrum m/e: 485 (M+H[0329] ⁺), 397
Anal. Calcd. for C[0330] ₂₆H₃₂N₂O₅S: C, 64.44; H, 6.65; N, 5.78 Found: C, 64.27; H, 6.64; N, 5.57
Reference 18 [0331]
N-(2-Carboxymethyl-3,4,7,8,9,10-hexahydro-2,5-dimethyl-2H-naphtho[2,1-e]pyran-6-sulfonyl)benzamidine was obtained according to a similar manner to that of Reference 12. [0332]
IR (CHCl[0333] ₃): 3420, 3320, 1710, 1632, 1530 cm⁻¹
[0334] ¹H-NMR (200 MHz, CDCl₃, δ): 1.45 (3H, s), 1.68 (4H, br s), 1.85-2.2 (2H, m), 2.6-2.75 (2H, m), 2.61 (3H, s), 2.67 (2H, s), 6.27 (1H, br s), 7.3-7.6 (3H, m), 7.75-7.8 (2H, m), 8.15 (1H, br s)
MASS spectrum m/e: 457 (M+H[0335] ⁺), 391
Reference 19 [0336]
A solution of dicyclohexylamine (0.22 g) in AcOEt (1 ml) was added to a solution of N-(2-carboxymethyl-3,4,7,8,9,10-hexahydro-2,5-dimethyl-2H-naphtho[2,1-e]pyran-6-sulfonyl)-benzamidine (0.55 g) in AcOEt (4 ml) and the mixture was stirred at room temperature to give N-(2-carboxymethyl-3,4,7,8,9,10-hexahydro-2,5-dimethyl-2H-naphtho[2,1-e]pyran-6-sulfonyl)benzamidine dicyclohexylamine salt as a solid (0.66 g). [0337]
mp: 188-190° C. [0338]
IR (Nujol): 3370, 1620, 1530 cm[0339] ⁻¹
MASS spectrum m/e: 457 (M+H[0340] ⁺ of free)
Anal. Calcd. for C[0341] ₃₆H₅₁N₃O₅S: C, 67.78; H, 8.06; N, 6.59 Found: C, 67.37; H, 8.26; N, 6.36

Claims

1. A linker of the following formula (I):

X—SO₂—R¹—(A)_m—R² (I)

wherein

R¹is a group of the formula (A), (B), (C), (D) and (E):

[wherein

R³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, R¹⁷and R¹⁸are the same or different hydrogen, lower alkyl or lower alkoxy, and

n is an integer of 1 to 3],

A is lower alkylene or a group of the formula:

—A¹—O—A²—

(wherein A¹and A²are each lower alkylene),

X is a leaving group, and

m is an integer of 0 or 1,

with proviso that A is (C₂-C₆)alkylene, and

m is an integer of 1,

when R¹is a group of the formula (A),

or a salt thereof.

2. A linker of

claim 1

, wherein

R¹is a group of the formula (A) wherein

R³, R⁴and R⁵are each lower alkyl,

A is (C₂-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1.

3. A linker of

claim 2

, wherein

R¹is a group of the formula:

A is trimethylene,

X is chloro, and

m is an integer of 1.

4. A linker of

claim 1

, wherein

R¹is a group of the formula (B) wherein

R⁶, R⁷, R⁸and R⁹are each lower alkyl,

R¹⁰is hydrogen, and n is an integer of 3,

A is (C₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A¹and A²are each (C₁-C₄)alkylene],

X is halogen, and

m is an integer of 0 or 1.

5. A linker of

claim 4

, wherein

R¹is a group of the formula:

A is methylene or —(CH₂)₂—O—CH₂—,

X is chloro, and

m is an integer of 1.

6. A linker of

claim 1

, wherein

R¹is a group of the formula (B) wherein

R⁶, R⁷, R⁸, R⁹and R¹⁰are each lower alkyl, and

n is an integer of 3,

A is (C₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A¹and A²are each (C₁-C₄)alkylene],

X is halogen, and

m is an integer of 0 or 1.

7. A linker of

claim 6

, wherein

R¹is a group of the formula:

X is chloro, and

m is an integer of 0, or

R¹is a group of the formula:

A is methylene or —(CH₂)₂—O—CH₂—,

X is chloro, and

m is an integer of 1.

8. A linker of

claim 1

, wherein

R¹is a group of the formula (C) wherein

R¹¹, R¹², R¹³, R¹⁴are each lower alkyl, and

R¹⁵is hydrogen,

A is (C₁-C₄)alkylene or a group of the formula:

—A¹—A²—

[wherein A¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1.

9. A linker of

claim 8

, wherein

R¹is a group of the formula:

A is methylene,

X is chloro, and

m is an integer of 1.

10. A linker of

claim 1

, wherein

R¹is a group of the formula (D) wherein

R¹⁶is lower alkyl,

A is (C₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1.

11. A linker of

claim 10

, wherein

R¹is a group of the formula:

A is trimethylene,

X is chloro, and

m is an integer of 1.

12. A linker of

claim 1

, wherein

R¹is a group of the formula (E) wherein

R¹⁷and R¹⁸are each lower alkyl,

A is (C₁-C₄)alkylene or a group of the formula:

—A¹—O—A²—

[wherein A¹and A²are each (C₁-C₄)alkylene],

X is halogen,

m is an integer of 1.

13. A linker of

claim 12

, wherein

R¹is a group of the formula:

A is methylene,

X is chloro, and

m is an integer of 1.

14. A derivative of the linker (I) of the present invention of the following formula:

AM—SO₂—R¹—(A)_m—R²

wherein AM is a residue of “amine compound”, and

R¹, R², A and m are each as defined in

claim 1

.